Recent

% | $
Quotes you view appear here for quick access.

Alkermes plc Message Board

  • shotanda2003 shotanda2003 Oct 25, 2010 11:13 PM Flag

    bydureon securities violations ?

    Alkermes, Inc. investor investigation over possible securities laws violations


    mail@shareholdersfoundation.com
    2010-10-25 16:19:15 - Investigation on behalf of investors of Alkermes, Inc. (NASDAQ:ALKS) over possible securities laws violations – ALKS stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com


    After Alkermes, Inc. lost more than 30% in stock value an investigation on behalf of investors in Alkermes, Inc. (NASDAQ:ALKS) shares concerning potential violations of Federal Securities laws in connection with the New Drug Application for Alkermes’s diabetes drug BYDUREON was announced.

    If you are an investor in shares of Alkermes, Inc. (NASDAQ:ALKS), and/or have any information relating to the investigation,


    you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

    The investigation by a law firm on behalf of investors in ALKS shares concerns whether Alkermes, Inc., certain of its officers, directors or insiders potentially violated any Securities laws in connection with the recent developments surrounding the diabetes drug BYDUREON (TM) (exenatide extended-release for injectable suspension.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ALKS
59.92-0.65(-1.07%)May 28 4:00 PMEDT